Oxford Cancer Biomarkers
PrivateLast Round
VC Round
Apr 3, 2023
Est. Valuation
$15.67M
Total Funding Raised
$6.47M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Oxford Cancer Biomarkers is a biotechnology company that develops and commercializes AI-driven, precision cancer diagnostic tests.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Medical AI, Healthcare Analytics, Medical Devices
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Oxford Cancer Biomarkers Comparables
Compare Oxford Cancer Biomarkers with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Novacyt S.A. | 79% | |
| EntroGen, Inc. | 77% | |
| Myriad Genetics | 76% | |
Oxford Cancer Biomarkers Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Apr 3, 2023 | ||||
| Grant | Mar 3, 2023 | ||||
| VC Round | Dec 14, 2015 | ||||
| Series A | Jan 18, 2012 |
Oxford Cancer Biomarkers Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Plutus Investment Group | VC Round |
| DHSC | Grant |
| University of Oxford | Series A |
| NHS AI Lab | Grant |
| Longwall Venture Partners | VC Round |
| National Institute for Health and Care Research | Grant |
| Oxford Technology | VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 15, 2026
Monthly visitors grew 50% MoM, reaching 1.3K.
- Apr 20, 2026
Monthly visitors grew 333% MoM, from 204 to 883.
Oxford Cancer Biomarkers Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Oxford Cancer Biomarkers's valuation, stock price, and market status.